Objectives: To determine the incidence of sepsis in Japanese intensive care units (ICUs) and to evaluate the impact of sepsis on mortality and length of stay (LOS).
Introduction
Sepsis is a clinical syndrome describing infection and subsequent systemic inflammatory response (1, 2) . Despite the availability of potent antibiotics, sepsis has been reported to be a major cause of death in hospitalized patients (3, 4) . In order to develop effective strategies for the prevention and treatment of sepsis, both clinicians and researchers require reliable information on the epidemiology of sepsis. There have been many studies estimating the incidence and outcome of sepsis in intensive care units (ICUs) (5-13), but reviews of these studies suggested a considerable variation in the reported rates (14) (15) (16) (17) . It is uncertain whether the estimates in specific populations are applicable to other populations. Little is known about the epidemiology of sepsis in the Japanese population.
The Japanese Ministry of Health, Labour, and Welfare established the Japanese Nosocomial Infection Surveillance (JANIS) system in July 2000, when participating hospitals routinely started to report their nosocomial infection surveillance data for a national database. In the ICU component of the JANIS system, all the patients admitted to the participating ICUs are enrolled in the survey. Data are collected by trained physicians and nurses in each ICU using a specific databaseoriented software, and reported to the data management office via the Internet on a monthly basis (18, 19) . Because the precise definitions of data items are incorporated into the databaseoriented software (20) , the JANIS system enables the establish-ment of a standardized and formatted database.
Using the large cohort database of the JANIS system, we determined the incidence of sepsis in Japanese ICUs and assessed the impact of sepsis on mortality and length of stay (LOS). In our previous study, we showed the impact of nosocomial infection (NI) on mortality in patients admitted to the ICUs (21) . In this study, we revealed that the development of sepsis leads to further increases in mortality and LOS in patients with NI.
Subjects and Methods
The ICU component of the JANIS system is the only source of information on the epidemiology of NI in Japanese ICUs. The details of data collection and quality control in the JANIS system have been described elsewhere (21) (22) (23) (24) . For all the patients admitted to the participating ICUs, the following data were collected using a specific database-oriented software in standardized forms: sex, age, underlying disease, severity of illness (APACHE II (25) ), ICU admission and discharge (date, time, and route), operation (elective and urgent), device use (ventilator, urinary catheter, and central venous catheter), infection (pneumonia, urinary tract infection, catheter-related blood stream infection, sepsis, wound infection, and others), and hospital discharge (date and outcome). APACHE II uses a point score based on the initial values of 12 routine physiological measurements, age, and previous health status to provide a general measure of severity of illness (25) . The point score was automatically computed with the database-oriented software when the relevant data were input. Information on infection included diagnosis date and culture results (strain and drugresistant pattern) for a maximum of three episodes for each infection site. A drug-resistant pattern was recorded for each pathogen in compliance with the database-oriented software.
Infections were diagnosed according to the JANIS definitions (20) , which are based on and modified from those of the National Nosocomial Infections Surveillance (NNIS) system in the United States (26) . A diagnosis of sepsis was defined as the presence of infection along with at least one of the following clinical manifestations: (1) body temperature ≥38°C or ≤36°C, (2) heart rate ≥90 bpm, (3) respiratory rate ≥20 bpm or PaCO 2 ≤32 mmHg, or (4) white blood cell count ≥12000/mm 3 or ≤4000/mm 3 . Causative pathogens were classified as drugsusceptible or drug-resistant on the basis of the data on the drug-resistant pattern.
From the JANIS database for the period between July 2002 and July 2004, we identified 28 ICUs where more than 100 patients were available for analysis. The study cohort consisted of 21,895 eligible patients, aged 16 years or older, who stayed in the ICU for 24 to 1000 hours and were not transferred to another ICU. They were surveyed for the diagnosis of sepsis during the ICU stay. The incidence of sepsis was determined in the cohort of 21,667 patients, excluding 228 who had met the definition of sepsis on ICU admission. The incidence of sepsis was calculated as the total number of sepsis episodes divided by (1) the total number of admissions (×100) (i.e., cumulative incidence) or (2) the total number of patientdays (×1000) (i.e., incidence rate) (27) . The effects of sepsis on mortality and LOS were assessed in the cohort of 20,909 patients, excluding 986 who had been infected on ICU admission. The 20,909 patients were classified into the following groups: (1) those who developed at least one infection and subsequent sepsis during the ICU stay (n=168; NI patients with sepsis), (2) those who developed at least one infection during the ICU stay but did not develop sepsis (n=760; NI patients without sepsis), and (3) those who did not develop infection during the ICU stay (n=19,981; patients without infection). Crude mortality was calculated as the total number of deaths during the ICU stay divided by (1) the total number of admissions (×100) or (2) the total number of patient-days (×1000). LOS was summed up for patients who were discharged from the ICU alive.
We observed the ethical guidelines for epidemiological studies by the Japanese Ministry of Health, Labour, and Welfare and the Japanese Ministry of Education, Culture, Sports, Science, and Technology. We paid particular attention to the protection of the anonymity of the patients and the confidentiality of the available data.
Statistical analyses
Statistical analyses were performed with the Statistical Analysis Systems (SAS, version 8.2). The chi-square test was used to compare the distributions of the characteristics of the patients. To examine the difference in the incidence of sepsis, incidence curves from ICU admission were computed using the Kaplan-Meier method and compared using the log rank test. Moreover, adjusted hazard ratio (HR) with 95% confidence interval (CI) for the incidence of sepsis was calculated using Cox's proportional hazard model (28) . To examine the difference in mortality, the proportions of deceased patients were compared using the chi-square test. Moreover, standardized mortality ratio (SMR) was calculated by the indirect standardization method on the basis of the crude mortality in the patients without infection for respective APACHE II categories (0-10, 11-20, and 21+). Mean LOS for survivors was assessed by the two-way analysis of variance with adjustment for APACHE II. Because LOS had a skewed distribution, the logarithms of LOS, which would be normally distributed, were analyzed (29, 30) . The back-transformed (i.e., antilog) means and 95% CIs are shown in the Results section. All statistics were two-tailed, and a value of p<0.05 was considered to be significant.
Results

Incidence of sepsis
Sepsis was diagnosed in 450 patients (2.1%), with 228 meeting the definition of sepsis on ICU admission and 222 during the ICU stay. There were no significant differences in sex, age, and APACHE II distributions between the patients diagnosed on ICU admission and the patients diagnosed during the ICU stay. Drug-resistant pathogens were detected in 22.9% of the sepsis episodes. This rate was significantly higher in the patients diagnosed during the ICU stay (27.0%) than in the patients diagnosed on ICU admission (18.9%). Table 1 shows the incidences of sepsis in the cohort of 21,667 patients without sepsis on ICU admission. The overall incidence of sepsis was 1.02/100 admissions or 2.00/1000 patient-days. Of the 222 sepsis episodes, 29.3% occurred within the first 3 days of the ICU stay and 59.5% occurred within the first week of the ICU stay. The percentage of drug-resistant pathogens in the sepsis episodes increased with LOS: 22.0% in the cases developed within the first week of the ICU stay vs. 34.4% in the cases developed at least 7 days after ICU admission (p<0.05). In the comparison of incidence curves, being male, a high APACHE II, urgent operation, ventilator use, and central venous catheter use were significantly associated with a high incidence of sepsis; no significant difference was found in age and urinary catheter use. Multivariate analysis showed a significantly higher HR for the incidence of sepsis in men (1.54 
Outcome of sepsis
Over 103,765 patient-days of the 20,909 patients, there were 928 episodes of NI including 168 episodes of sepsis (18.1%). Table 2 shows the characteristics of the patients without infection, the NI patients without sepsis, and the NI patients with sepsis. The percentages of men, high APACHE II, ventilator use, central venous catheter use, and urgent operation in the patients who developed NI were significantly higher than those in the patients without infection. The percentages of high APACHE II and ventilator use in the NI patients with sepsis were significantly higher than those in the NI patients without sepsis. Table 3 shows the crude mortalities of the patients without infection, the NI patients without sepsis, and the NI patients with sepsis. The proportion of deceased patients significantly differed between the groups (p<0.001). The mortality of the NI patients with sepsis was higher than that of the patients without infection and the NI patients without sepsis. The mortality increased with APACHE II in all the groups, but this increase was more pronounced in the NI patients without sepsis than in those with sepsis. SMR was determined to be 1.18 (95% CI: 0.82-1.21) in the NI patients without sepsis and 2.43 (95% CI: 1.88-3.09) in the NI patients with sepsis.
For the patients who were discharged from the ICU alive, a prolonged ICU stay was more frequently observed in those who developed NI than in those without infection: the percentages of LOS ≥14 days and ≥28 days were 66.7% and 21.6% in the NI patients with sepsis and 50.2% and 10.4% in the NI patients without sepsis compared with 4.1% and 0.4% in the patients without infection (p<0.001), respectively. After adjusting for APACHE II, mean LOS for survivors was calculated to be 11.8 days (95% CI: 11.3-12.4) in the NI patients without sepsis and 15.0 days (95% CI: 13.3-17.0) in the NI patients with sepsis compared with 3.8 days (95% CI: 3.8-3.9) in the patients without infection.
Of the NI patients with sepsis, 126 (74.6%) were infected by drug-susceptible pathogens and 43 (25.4%) were infected by drug-resistant pathogens. Mortality was significantly higher in the patients infected by drug-resistant pathogens (53.5/100 admissions, 26.6/1000 patient-days) than in the patients infected by drug-susceptible pathogens (34.4/100 admissions, 18.3/1000 patient-days). After adjusting for APACHE II, mean LOS for survivors was calculated to be 16.4 days (95% CI: 14.1-19.0) in the patients infected by drug-susceptible pathogens and 16.3 days (95% CI: 12.5-21.1) in the patients infected by drugresistant pathogens.
Discussion
Using the large cohort database of the JANIS system, we determined the incidence of sepsis in Japanese ICUs and assessed the impact of sepsis on mortality and LOS. To our knowledge, this is the first report on the epidemiology of sepsis in the Japanese population. The JANIS system takes various measures to establish a standardized and formatted database: a specific database-oriented software and a written operating manual with uniform definitions and surveillance protocols are prepared in advance; workshops for data collectors are conducted on demand; and reliability checks are routinely performed at the data management office. Accordingly, this study can provide reliable information on the incidence and outcome of sepsis in Japanese ICUs.
In the 28 ICUs that participated in the JANIS system, the overall incidence of sepsis was 1.02/100 admissions or 2.00/ 1000 patient-days. This rate was considerably lower than that observed in previous multicenter cohort studies: 20% in 8 ICUs in the United States between 1993 and 1994 (6) (13) . In this study, the patients who met the definition of sepsis on ICU admission were excluded from the calculation of the incidence of sepsis, whereas in the previous studies, these patients were included. When we recalculated the incidence of sepsis in the total cohort of 21,895 patients, the overall incidence of sepsis was 2.06/100 admissions or 3.98/1000 patient-days. This study differed from the previous studies in definitions, surveillance protocols, and settings. Although it is difficult to compare the reported rates accurately, the incidence of sepsis in Japanese ICUs seems to be lower than that in ICUs in other countries.
As in other studies, being male, a high APACHE II, ventilator use, and central venous catheter use were significantly associated with an increased incidence of sepsis. These factors have also been reported to be risk factors of NI (22) . The increased incidence of sepsis in this study might be due in part to increasing NI in relation to these factors. Information on the risk factors of sepsis may be useful for identifying high-risk subgroups who need particular attention to prevent sepsis from developing during the ICU stay. Several studies have reported that organ dysfunction along with severity of illness and device use were significantly associated with an increased incidence of sepsis (5, 7, 12) . Moreover, patients admitted from medical and emergency surgical wards showed a higher incidence of sepsis than those admitted from surgical wards (5, 7, 12) ; however no significant association with operation was observed in this study. Further studies may be required to investigate the risk factors of sepsis in detail.
APACHE II is an indicator of severity of illness, which is commonly used for estimating the probability of death (25) . Mortality increased with APACHE II in the patients with NI, but this increase was more pronounced in the patients without sepsis than in those with sepsis. It seems that sepsis had greater and more direct effects on mortality than APACHE II. The patients with sepsis showed a significantly higher SMR and a significantly longer mean LOS than those without sepsis, suggesting that the development of sepsis imposes a substantial burden on patients with NI independent of severity of illness. Preventive measures against sepsis should be emphasized to improve survival and avoid prolonged hospitalization in patients admitted to the ICU. As a matter of course, basic infection control practices are indispensable for reducing the risk of NI. The patients with sepsis caused by drug-resistant pathogens showed a significantly higher mortality than those with sepsis caused by drug-susceptible pathogens. Many studies have compared the outcomes of sepsis caused by drug-resistant and drug-susceptible pathogens, which have varied from no difference in mortality to a significant increase in mortality (31) . Overall, drug-resistant pathogens contribute to increasing the mortality in patients with sepsis. Drug-resistant pathogens were frequently detected in the patients who developed sepsis during the ICU stay, and the percentage of drug-resistant pathogens in the sepsis episodes increased with LOS. Antibiotic use is one of the major determinants of the shift toward resistant strains (32) (33) (34) . Exposure to antibiotics may increase the probability of sepsis caused by drug-resistant pathogens with increasing LOS. An adequate antibiotic treatment along with preventive measures against sepsis should be emphasized to reduce the burden of sepsis in ICU patients (31, 35, 36) .
This study had the following potential limitations. First, organ dysfunction may be associated with the incidence and outcome of sepsis. Several studies have reported that organ dysfunction was significantly associated with an increased incidence of sepsis (5, 7, 12) . Patients with organ dysfunction in addition to sepsis are considered to have severe sepsis or septic shock (1, 2), and therefore a higher probability of death (14) (15) (16) (17) . Although organ dysfunction was not directly analyzed in this study, APACHE II was incorporated into the model as a composite index. SMR and mean LOS were calculated with adjustment for APACHE II. Second, antibiotic treatment may be an important determinant of mortality. Several studies have reported that patients who received adequate antibiotic treatment showed a significant lower mortality than those who received inadequate antibiotic treatment (31, (37) (38) (39) . Unfortunately, the JANIS system does not collect information on antibiotic use. The impact of sepsis on mortality and LOS in this study may be underestimated or overestimated. Third, the JANIS system recruits multidisciplinary hospitals with more than 200 beds. Most of the participating ICUs are in national university hospitals, where the levels of hospital infection control are likely to be high in Japan. The findings of this study may not represent the average for Japanese hospitals. Further studies may be required to confirm our findings in other hospitals.
In conclusion, sepsis is not very common in Japanese ICUs, but its development leads to further increases in mortality and LOS in patients with NI. Because of the possible effect of drug-resistant pathogens on mortality, an adequate antibiotic treatment along with preventive measures against sepsis should be emphasized to reduce the burden of sepsis in ICU patients. Clinicians are supposed to select antibiotics with an appropriate spectrum covering the likely causative pathogens even before they know the culture results. Knowledge of causative pathogens with their drug-resistant patterns may be useful for avoiding inadequate antibiotic treatment. The SOAP study showed that the distribution of causative pathogens was differed between ICU-acquired and non-ICU-acquired sepsis episodes and also between medical and surgical admissions (13) . The distribution of causative pathogens in Japanese ICUs should be explored in detail to provide useful information for clinicians.
